Insights On Pharmaceutical Packaging
-
Optimal Syringe Carton Design To Meet Drug Manufacturers' Needs
8/1/2024
Learn about the advantages of an optimal packaging design and the resulting benefits of its implementation to the overall process.
-
CDMO Installs Toploading Packaging Solutions To Meet Small Lot Needs
7/30/2024
Gain insight into the solutions a global leader in contract packaging and clinical supply services relies on to address clients' evolving needs for the small lot packaging of specialized and personalized drugs.
-
Low Temperature Storage Containment For Vial And Syringe Systems
6/20/2025
With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.
-
Setup Made Simple With The BioTitan Retention Device
5/27/2025
Find out how quick and simple it is to set up an assembly secured with the Thermo Scientific BioTitan Retention Device.
-
Navigating Primary Packaging Challenges, Solutions For Emerging Innovators
12/5/2024
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
-
The Rising Need For Flexibility In Blister Packaging For CDMOs And Drug Manufacturers
8/1/2024
In the pharmaceutical industry, processes are subject to continuous change due to evolving requirements and regulations. Consequently, pharmaceutical companies and contract packagers often require adaptable packaging solutions, such as blister machines, to meet these dynamic needs.
-
Why Compounding Pharma Manufacturers Should Evaluate BFS Systems
12/5/2024
Discover how BFS technology offers compounding pharmacies and 503B facilities enhanced sterility, reduced errors, cost savings, and superior product integrity for aseptic pharmaceutical manufacturing.
-
Film Sealing In Automation
6/16/2025
Explore essential considerations for choosing the right sealing method in product development with insights on the benefits and drawbacks of different techniques for various industries.
-
Meeting Annex 1: A Proactive Approach To Regulatory Compliance
3/4/2025
It was imperative for a large European CMO that produces multiple biologic drugs to select the right product quality and value for each customer to comply with the August 2023 revision to the EU GMP Annex 1.
-
De-Risking The Transition From Vial To Drug-Device Combination Product
7/25/2025
When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.